Autologous Bone Marrow Transplantation

Autologous transplantation:

It implies transplanting native stem cells, or in other words, own stem cells of the patient.

This type of transplantation is usually preferred for lymphomas, multiple myeloma (MM), germ cell tumors and acute leukemia –albeit rare.

Autologous stem cell transplantation: It is reserved for reinforcing outcomes of chemotherapy in patients with multiple myeloma or with some high-risk lymphomas. Autologous stem cell transplantation is preferred for recurrences of many lymphomas.

Prior to the autologous stem cell transplantation, your cardiac and respiratory functions are assessed and investigations are made regarding contraindications of transplantation.

When patient’s own stem cell is collected, presence of diseased cells among stem cells is a risk that should be taken into account. Accordingly, when cryopreserved stem cells are re-transplanted to the patient, diseased cells that are possibly found among healthy stem cells may lead to recurrence.

Related articles